These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12189362)

  • 41. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.
    Hain RD; Hardcastle A; Pinkerton CR; Aherne GW
    Br J Clin Pharmacol; 1999 Jul; 48(1):37-42. PubMed ID: 10383558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentration-effect relationships of morphine and morphine-6 beta-glucuronide in the rat.
    van Crugten JT; Somogyi AA; Nation RL; Reynolds G
    Clin Exp Pharmacol Physiol; 1997 May; 24(5):359-64. PubMed ID: 9143788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome.
    Skarke C; Schmidt H; Geisslinger G; Darimont J; Lötsch J
    Br J Clin Pharmacol; 2003 Aug; 56(2):228-31. PubMed ID: 12895198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
    Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
    Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disposition of morphine-6-glucuronide and morphine in healthy volunteers.
    Hanna MH; Peat SJ; Knibb AA; Fung C
    Br J Anaesth; 1991 Jan; 66(1):103-7. PubMed ID: 1997044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
    Wu D; Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Population pharmacokinetics of heroin and its major metabolites.
    Rook EJ; Huitema AD; van den Brink W; van Ree JM; Beijnen JH
    Clin Pharmacokinet; 2006; 45(4):401-17. PubMed ID: 16584286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Plasma pharmacokinetics of morphine and morphine-6-glucuronide using high performance liquid chromatography and colorimetric detection].
    Barberi-Heyob M; Merlin JL; Krakowski I; Kettani C; Collin E; Poulain P
    Bull Cancer; 1991 Nov; 78(11):1063-70. PubMed ID: 1369552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative disposition of morphine-3-glucuronide during separate intravenous infusions of morphine and morphine-3-glucuronide in sheep. Importance of the kidney.
    Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1995 Mar; 23(3):334-42. PubMed ID: 7628298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children.
    Verscheijden LFM; Litjens CHC; Koenderink JB; Mathijssen RHJ; Verbeek MM; de Wildt SN; Russel FGM
    PLoS Comput Biol; 2021 Mar; 17(3):e1008786. PubMed ID: 33661919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
    Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.
    Franken LG; Masman AD; de Winter BC; Koch BC; Baar FP; Tibboel D; van Gelder T; Mathot RA
    Clin Pharmacokinet; 2016 Jun; 55(6):697-709. PubMed ID: 26715216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
    Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
    Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability of a morphine suppository is increased after intracolostomal administration in colostoma-constructed rabbits.
    Nagasawa K; Kintsuji S; Nakanishi H; Nagai K; Fujimoto S
    Int J Pharm; 2003 Oct; 265(1-2):65-73. PubMed ID: 14522119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
    Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
    Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
    Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.